Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
Camillo Porta1, Chiara Paglino1, Luciano Mutti21Medical Oncology and Laboratory of Pre-Clinical Oncology and Developmental Therapeutics, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy; 2Local Health Authority 6, Piedmont, ItalyAbstract: Ribonucleases are a superfamily of enzymes...
Guardado en:
Autores principales: | Camillo Porta, Chiara Paglino, Luciano Mutti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dbceac834b74d9c820efe3118c15925 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Junji Furuse
Publicado: (2008) -
Pediatric Peritoneal Epithelial Malignant Mesothelioma Case Report
por: Elizabeth Bellew, et al.
Publicado: (2021) -
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study
por: Cova E, et al.
Publicado: (2019) -
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Nobukazu Fujimoto, et al.
Publicado: (2021) -
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
por: Chiara De Santi, et al.
Publicado: (2017)